TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 1 | 5 | -4 | 2 | -35 | -42 | -35 | -18 |
| S | %wins | 0 | 100 | 0 | 100 | 100 | 100 | 67 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/26/09 16:02 | 6/24/09 | CLDX | Celldex Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Medarex Inc | NJ | T | S | -14,300 | 7.15 | 6 | -2,000 | -40 | 2,961 | D | -22 | -41 | 27 | 11 | -6 | -29 | -13 | -8 | 5 | -4 | 2 | -35 | -42 | -35 | |
6/25/08 16:54 | 6/23/08 | AVAN | Avant Immunotherapeutics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Medarex Inc | NJ | T | S | -4,343 | 12.35 | 0 | -352 | -7 | 4,961 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |